I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
C series
—
17.6.2024
(Joined Cases C-309/22 and C-310/22, (1) PAN Europe (Assessment of endocrine disrupting properties))
(Reference for a preliminary ruling - Approximation of laws - Regulation (EC) No 1107/2009 - Authorisation for placing plant protection products on the market - Examination for authorisation - Article 4 - Article 29 - Conditions - No harmful effect - Criteria - Endocrine disrupting properties - Regulation (EU) 2018/605 - Precautionary principle - Current scientific and technical knowledge)
(C/2024/3568)
Language of the case: Dutch
Applicant: Pesticide Action Network Europe (PAN Europe)
Defendant: College voor de toelating van gewasbeschermingsmiddelen en biociden
Intervening parties: Adama Registrations BV (Adama) (C-309/22), BASF Nederland BV (C-310/22)
Article 29(1)(a) and (e), the second subparagraph of Article 4(1), and Article 4(3) of Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, as amended by Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties, read in conjunction with point 3.6.5 of Annex II to Regulation No 1107/2009, as amended,
must be interpreted as meaning that the competent authority of a Member State charged with the task of assessing an application for authorisation to place a plant protection market on the market is required, as part of the examination of that application, to take into account the adverse effects that the endocrine disrupting properties of an active substance contained in that product may cause for human beings, having regard to the relevant and reliable scientific or technical knowledge available at the time of that examination and which is, in particular, reproduced in the criteria laid down in point 3.6.5.
* * *
ELI: http://data.europa.eu/eli/C/2024/3568/oj
ISSN 1977-091X (electronic edition)
—